UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053866
Receipt number R000061488
Scientific Title Assessment of the Utility of Goggle-Type Contrast Sensitivity Measurement Device
Date of disclosure of the study information 2024/03/15
Last modified on 2024/03/14 18:09:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of the Utility of Goggle-Type Contrast Sensitivity Measurement Device

Acronym

Assessment of the Utility of Goggle-Type Contrast Sensitivity Measurement Device

Scientific Title

Assessment of the Utility of Goggle-Type Contrast Sensitivity Measurement Device

Scientific Title:Acronym

Assessment of the Utility of Goggle-Type Contrast Sensitivity Measurement Device

Region

Japan


Condition

Condition

Cases of cataracts or suspected cataracts

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Comparison between Contrast Sensitivity Measurement Results Using a new Contrast Sensitivity Measurement Device and Those Using Existing Contrast Sensitivity Measurement Devices

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Contrast sensitivity

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

As a pre-examination preparation, obtain information on the date of birth, gender, visual acuity, and refractive power. Subsequently, perform contrast sensitivity measurements once or multiple times using existing contrast sensitivity devices and a new contrast sensitivity measurement device.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

a. cataract patient
b. Age of 18 years or more
c. Patients who can agree to participate, in his/her own intention

Key exclusion criteria

None

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Shirou
Middle name
Last name Kawasaki

Organization

KAWASAKI EYE CLINIC

Division name

-

Zip code

791-8065

Address

1-1 Misugi-cho, Matsuyama City, Ehime Prefecture, Japan

TEL

089-951-6110

Email

kawasaki.eye.clinic@ray.ocn.ne.jp


Public contact

Name of contact person

1st name Shirou
Middle name
Last name Kawasaki

Organization

KAWASAKI EYE CLINIC

Division name

-

Zip code

791-8065

Address

1-1 Misugi-cho, Matsuyama City, Ehime Prefecture, Japan

TEL

089-951-6110

Homepage URL


Email

kawasaki.eye.clinic@ray.ocn.ne.jp


Sponsor or person

Institute

KAWASAKI EYE CLINIC

Institute

Department

Personal name



Funding Source

Organization

FINDEX Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

FINDEX Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

FINDEX Inc. Research Ethics Committee

Address

26F Tokyo Sankei Building, 1-7-2 Otemachi, Chiyoda-ku, Tokyo

Tel

03-6271-8958

Email

qms@findex.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 03 Month 14 Day

Date of IRB


Anticipated trial start date

2024 Year 03 Month 15 Day

Last follow-up date

2026 Year 03 Month 13 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 03 Month 14 Day

Last modified on

2024 Year 03 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061488


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name